PPARGC1A and type 2 diabetes mellitus: This pathway, namely adipocytokine signaling, also comprises PGC-1α, a protein that is a potential target for treating type II diabetes (it is indeed involved in the regulation of glucose metabolism) and that has been shown to decrease the hyperglycemic-mediated production of beta-amyloid [57].